Atrial Fibrillation Burden and Clinical Outcomes in Patients with BTK Inhibitor Cardiotoxicity: nature.com/articles/s4137… Thanks Leukemia Journal for publishing this work. #CardioOnc #CLL #BTK #AtrialFibrillation #leukemia Alan Gambril, MD International Cardio-Oncology Society Eric H Yang, MD

SGLT2i and Primary Prevention of Cancer Therapy–Related Cardiac Dysfunction in Patients With Diabetes SGLT2i administration was associated with a significantly decreased risk of developing CTRCD in patients with T2DM and cancer. jacc.org/doi/10.1016/j.…

Join the ESC Council of Cardio-Oncology for Pink October – Supporting Breast Cancer Awareness #Breastcancer treatment goes beyond treating the tumour. Protecting the heart during and after treatment is essential for long-term health #ESCCardioOnco #cardiooncology

📖 💖 It’s time for the next chapter in cardio-oncology… Join us for the inaugural #ESCardioOnco2025 conference, where specialists in cardiology, oncology, haematology and related fields will come together to share knowledge and build valuable connections in this dynamic and

Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: a meta-analysis. Read more in #EHJ: academic.oup.com/eurheartj/adva… #AF #outcome European Society of Cardiology European Society of Cardiology Journals

MasterClass on afib in cancer patients. Getting down to the basic science level to understand the mechanisms Mike Fradley, MD International Cardio-Oncology Society Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA, FESC

Absolutely FANTASTIC to see trials specific to our oncological patients to detect early arrhythmias #FutureOfCardioOnc Mike Fradley, MD Diego Sadler MD FACC Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA, FESC Eric H Yang, MD Vlad Zaha AHA Science American Heart Association #AHA24

“As the global population grows older, we will see more and more people with #cancer and thus more and more with toxic CVD side-effects of cancer treatment,” Dr Teresa López-Fernandez says. #ESCCardioOnco2025 to focus on this growing epidemic. Read more: bit.ly/3ZPZ2eY

Very excited to share our our recent work and a JACC: CardioOncology/ ACC25 simultaneous publication evaluating cardiac findings and outcomes among patients with ICI myocarditis and concomitant myopathy #CardioOnc #CardioOncology #JACCCardioOnc jacc.org/doi/10.1016/j.…

Update on preclinical models of cancer therapy-related cardiac dysfunction: A scientific statement of #HFA of the ESC, the ESC Council of #CardiOncology, & the ESC Working Group on Cellular Biology of the Heart onlinelibrary.wiley.com/doi/full/10.10… Henry Han Amr Abdin Giuseppe Galati

#Hematology Diagnostic Accuracy of Apple Watch Electrocardiogram for Atrial Fibrillation: A Systematic Review and Meta-Analysis | ⁦JACC Journals⁩ Very interesting for patients with cancer at high risk of #AFib #JACCCardioOnc #CardioOnc jacc.org/doi/10.1016/j.…

ESC Board Cardio oncology meeting today. Shaping the future of Cardio-Oncology. The conference starts tomorrow. Do join us !

Let's kick off the conference 🤗📷 We are ready with the #ESCardioOnco2025 Social Media Ambassadors 🔥 Follow and connect with them👉Borja Ibanez Victoria Delgado Raul Cordoba, MD, PhD Clara Llamedo, MD Mike Fradley, MD Novi Yanti Sari Massimiliano Camilli Pedro Moliner They'll be bringing you

Hang on! The first #ESCardioOnco2025 Congress is about to start

#ESCardioOncology2025 starts right now‼️ More than 70 countries sharing cardio-oncology knowledge. Let’s go‼️ European Society of Cardiology Teresa López Fdez

💣💣💣‼️ #ESCardioOnco2025 New ESC journal: EHJ-CardioOncology will arrive in 2026 😱 European Society of Cardiology Journals

Wow 🤯 so many #epeeps abstracts . Amazing work presented during moderated poster session and even several interventional EP. #ESCardioOnco2025 #jacccardioonc International Cardio-Oncology Society

Dr Fradley stresses the importance of QT interval BUT we need to do a better job in measuring! ⁦International Cardio-Oncology Society⁩ ⁦European Society of Cardiology⁩

Check out our #ESCardioOnco2025 finalist study on ICI-associated myocarditis!📍we analyzed EMB samples: ➡️ Most cases were “borderline” per Dallas criteria ➡️ Thymoma, ICI monotherapy, and metastatic cancer linked to definite myocarditis #CardioOncology #Myocarditis #ICI #ESC2025

Reduced echo monitoring every 6 months is safe and feasible for low risk HER2+ BC patients, per #Anthony Yu et al. A key step toward evidence-based, risk-adapted monitoring. #CardioOnc #CTRCD JACC Journals Kazuhiro Sase dineshpmcc International Cardio-Oncology Society